Newsroom
Sorted by: Latest
-
INNATE PHARMA PRÉSENTE SES RÉSULTATS FINANCIERS ET L’AVANCÉE DE SON PORTEFEUILLE POUR L’ANNÉE 2025
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui ses résultats financiers consolidés au 31 décembre 2025. Les comptes consolidés sont joints au présent communiqué. « L'année 2025 a été marquée par une exécution solide de l'ensemble de notre portefeuille. Avec la finalisation du design de TELLOMAK-3 et l’autorisation de la FDA, nous prévoyons d’initier l’essai confirmatoire de Phase 3 a...
-
Innate Pharma Reports Full Year 2025 Financial Results and Business Update
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today reported its business update and consolidated financial results for the year ending December 31, 2025. The consolidated financial statements are attached to this press release. “2025 has been a year of strong execution across our portfolio. With the TELLOMAK-3 design finalized and FDA clearance in hand, lacutamab is planned for confirmatory Phase 3 initiati...
-
Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification
SAN DIEGO--(BUSINESS WIRE)--Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to announce that its IdentiClone Dx IGH Assay has received In Vitro Diagnostic Regulation (IVDR) 2017/746 Class C certification in the European Union (EU). Commercial availability of the IVDR-certified assay is anticipated by early April 2026. The IVDR replaces the former In Vitro Diagnostics Directive (IVDD), introducing significantly more stringent require...
-
Hytera Introduces PNC660 450MHz: New Device Certified for Power and Energy Mission-Critical Networks
BARCELONA, Spain--(BUSINESS WIRE)--Hytera unveiled the PNC660 450MHz MCX Smart Device – an advanced mission-critical terminal for private 450MHz LTE and 5G networks at MWC Barcelona....
-
H2O.ai and CTC Global Singapore Have Partnered Together To Democratize Agentic AI Across APAC
SINGAPORE--(BUSINESS WIRE)--H2O.ai, the leading open-source AI platform company, and CTC Global Singapore, a trusted technology integrator across Asia Pacific, today announced a collaboration to accelerate enterprise AI adoption across the region. The collaboration was formalized at a signing ceremony in Singapore, marking a milestone in delivering trusted, production-grade Agentic AI designed to support users in secure and regulated environments. This partnership directly addresses the evolvin...
-
Liberty Energy Inc. Announces Pricing of Upsized $475.0 Million Convertible Senior Notes Offering
DENVER--(BUSINESS WIRE)--Liberty Energy Inc. (NYSE: LBRT) (“Liberty”) today announced the pricing of, and that it has agreed to sell, $475.0 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the “Notes”) in a private offering (the “Notes Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Liberty also granted the initial purchasers an option to purch...
-
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
OSAKA, Japan--(BUSINESS WIRE)--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) today announced that Ono submitted an application for the manufacturing and marketing approval of ripretinib (DCC-2618), developed by Deciphera Pharmaceuticals, Inc. (“Deciphera”), for the indication of “gastrointestinal stromal tumor that has progressed following cancer chemotherapy.” This application is based on the results of the INVICTUS study, a global Phase 3 clinical...
-
Anaergia Reports Positive Adjusted EBITDA1 and Strong Revenue Growth in Fiscal 2025
BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia (TSX: ANRG; OTCQX:ANRGF) reports positive Adjusted EBITDA, 61% revenue growth and Revenue Backlog up 149% in fiscal 2025....
-
Taco Bueno Turns Up the Heat with New Fuego Menu Line
DALLAS--(BUSINESS WIRE)--Taco Bueno launches Fuego Fuel: a limited-time spicy lineup with bold Tex-Mex flavors....
-
While Private Equity Firms Abandon Homeowners Overnight, Evolve Construction Is Planting Roots in Kansas and Missouri
KANSAS CITY, Mo.--(BUSINESS WIRE)--Evolve Construction operates across 35+ markets in the U.S. with HAAG & IICRC certification, proprietary AI, and a 100% satisfaction guarantee....